Abstract：Objective To investigate the clinica effect of Lianbizhi Injection combined with Ceftriaxone Sodium and Tazobactam Sodium in the treatment of senile pneumonia. Methods A total of 90 elderly patients with pneumonia admitted to our hospital from June 2017 to June 2018 were selected as the study subjects. According to the random number table method, they were divided into the control group (45 cases) and the combined group (45 cases). The control group was treated with Ceftriaxone Sodium and Tazobactam Sodium, the combined group was treated with Lianbizhi Injection and Ceftriaxone Sodium and Tazobactam Sodium. After 2 weeks of treatment, the improvement of symptoms,medication effect and inflammation indicators before and after treatment were compared between the two groups. Results The antipyretic time, cough disappearance time and wheezing time in the combined group were shorter than those in the control group, and the differences were statistically significant (P＜0.05). The total effective rate of the combined group was higher than that of the control group , and the difference was statistically significant (P＜0.05). After treatment, the levels of C-reactive protein (CRP), tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) in the two groups were lower than those before treatment, and the levels of CRP, TNF-α and IL-6 in the combined group were lower than those in the control group, and the differences were statistically significant (P＜0.05). Conclusion On the basis of Ceftriaxone Sodium and Tazobactam Sodium combined with Lianbizhi Injection can significantly improve the clinical symptoms and inflammatory indicators of senile pneumonia patients, with good application effect.
Park HJ，Lee SM，Choe J，et al.Prediction of treatment response in patients with chronic obstructive pulmonary disease by determination of airway dimensions with baseline computed tomography[J].Korean J Radiol，2019，20（2）：304-312.
京公网安备 11010502046607号